ADAMTS13 and Thrombocytopenia: As our patients had been under medical care since the first year of life, without thrombocytopenia, and after treatment they remained with normal platelets for years and without signs of TMA, it is very unlikely that this is congenital PTT, although they did not have ADAMTS-13 dosage after the end of treatment.